|Precautions||MMK1 Protein is for research use only and not for use in diagnostic or therapeutic procedures.|
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abgent to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
email@example.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Chemotactic factors from both Gram-positive and Gram-negative bacteria are short peptides with N-formyl methionine at the N-terminus (extensively reviewed in reference 1). These peptides are released from bacteria during infection and activate formyl peptide receptor (FPR), a member of G-protein coupled receptors (GPCRs). In human, the FPR family consists mainly of three receptors, FPR1, FPR2/ALX (formerly FPRL1), and FPR3 (formerly FPRL2) which all couple to the Gi subtype of G-proteins and ultimately lead to the activation of phospholipase C and intracellular Ca2+increase1,2.
MMK1 is a selective and potent agonist of the Formylpeptide receptor FPR23, which was originally derived from a random peptide library and was identified by a novel autocrine selection method in yeasts engineered to express human FPR24.
FPR2 is expressed in the promyelocytic leukemia cell line HL-60 as well as in the chronic myelogenous leukemia cell line K5625. In human neutrophils, 1 µM MMK1 induces Ca2+ influx which is blocked by the specific FPR2 antagonist WRW46.
Resveratrol, a constituent of grape seeds, induces Ca2+ influx in human monocytes which is blocked by10 µM MMK1, demonstrating that the inhibition of chemoattractant receptors contribute to the anti-inflammatory properties of resveratrol7.
1 . Ye, R.D. et al.(2009)Pharmacol. Rev.61, 119.
2 . Le, Y. et al.(2002)Trends Immunol. 23, 541.
3 . Hu, J.Y. et al. (2001)J. Leukoc. Biol. 70,155.
4 . Klein, C. et al.(1998)Nat. Biotechnol.16,1334.
5 . See Applications for Anti-Human FPR2/ALX (extracellular).
6 . Bae, Y.S. et al. (2004)J. Immunol. 173,607.
7 . Tao, H. et al. (2004)Cell. Mol. Immunol. 1,50.
If you have used an Abgent product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at firstname.lastname@example.org.